Related Experiment Video
Updated: Jun 4, 2026
05:09
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
Published on: April 28, 2023
Correlation between urological alpha1-AR antagonist medication and changed intraoperative iris behavior
Karin Horvath1, Florina Vultur
1Ophthalmology Clinic, University of Medicine and Pharmacy, Targu-Mures, Romania, kuhorvath@gmail.com
International Ophthalmology
|February 1, 2011
Summary
Intraoperative floppy iris syndrome (IFIS) occurred in 2.96% of patients taking alpha-blockers during cataract surgery. Management strategies, including intracameral epinephrine, effectively controlled IFIS without complications.
Area of Science:
- Ophthalmology
- Surgical Science
Background:
- Intraoperative floppy iris syndrome (IFIS) is a recognized complication during cataract surgery.
- Alpha-blocker medications, particularly tamsulosin, are strongly associated with IFIS.
- Understanding IFIS incidence, etiology, and management is crucial for surgical outcomes.
Purpose of the Study:
- To determine the incidence and etiology of IFIS during phacoemulsification.
- To evaluate management strategies for IFIS during cataract surgery.
- To report on intraoperative complications associated with IFIS.
Main Methods:
- A prospective, observational study of 439 eyes undergoing cataract surgery by a single surgeon.
- Patients' drug history (specifically alpha-blocker use) was recorded.
- IFIS presence, management, and intraoperative complications were documented.
Main Results:
- IFIS occurred in 2.96% of patients taking alpha-1 antagonists.
- An "IFI-like syndrome" was observed in 5.47% of patients.
- Intracameral epinephrine and specific surgical techniques (vertical chop, smaller incisions) managed IFIS effectively.
Conclusions:
- Alpha-blocker medication is a significant risk factor for IFIS.
- IFIS can be managed effectively during surgery with techniques like intracameral epinephrine.
- No intraoperative or postoperative complications were reported in this study.
More Related Videos
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:24Cholinergic Antagonists: Pharmacokinetics
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.